Suppr超能文献

一项用于早期检测肝细胞癌的监测计划的疗效

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

作者信息

Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E

机构信息

Istituto di Clinica Medica Generale e Terapia Medica, University of Bologna, Italy.

出版信息

Cancer. 1996 Sep 1;78(5):977-85. doi: 10.1002/(SICI)1097-0142(19960901)78:5<977::AID-CNCR6>3.0.CO;2-9.

Abstract

BACKGROUND

Contrasting data have so far been reported on the utility and efficacy of screening patients with cirrhosis for early detection of hepatocellular carcinoma (HCC). The goal of this study was to evaluate the efficacy of a regular ultrasonographic and laboratory follow-up for the early detection of small HCC, and to identify parameters correlated with a higher risk of developing HCC.

METHODS

One hundred and sixty-four consecutive patients with liver cirrhosis living in Emilia Romagna, Italy, were enrolled in the period 1989-1991. All patients underwent clinical, biochemical, and ultrasonographic evaluations at entry and at 3- and 6-month intervals during follow-up.

RESULTS

By April 1995, 34 patients had developed HCC. In 76% of the patients, ultrasonography identified HCC when it was still single and small (< 4 cm). At discriminant, logistic regression and univariate analyses, sex and the entry concentration of alkaline phosphatase, alpha-fetoprotein, gamma-glutamyl transpeptidase, and albumin were associated with a higher risk of developing HCC, whereas at multivariate analysis (Cox's model), only sex and the entry concentration of alkaline phosphatase, albumin, and alpha-fetoprotein were independently and significantly related to the appearance of HCC.

CONCLUSIONS

A regular ultrasonographic follow-up, timed at 3- to 6-month intervals according to the risk of HCC development in patients with cirrhosis, allows the detection of liver carcinoma at an early stage in a high proportion of patients, possibly improving the prognosis of the disease.

摘要

背景

迄今为止,关于对肝硬化患者进行筛查以早期发现肝细胞癌(HCC)的实用性和有效性,已有相互矛盾的数据报道。本研究的目的是评估定期超声检查和实验室随访对早期发现小肝癌的有效性,并确定与发生HCC风险较高相关的参数。

方法

1989年至1991年期间,连续纳入了意大利艾米利亚-罗马涅地区的164例肝硬化患者。所有患者在入组时以及随访期间每隔3个月和6个月进行临床、生化和超声检查评估。

结果

到1995年4月,34例患者发生了HCC。在76%的患者中,超声检查在HCC仍为单发且较小(<4 cm)时就检测到了。在判别分析、逻辑回归和单因素分析中,性别以及碱性磷酸酶、甲胎蛋白、γ-谷氨酰转肽酶和白蛋白的入组浓度与发生HCC的风险较高相关,而在多因素分析(Cox模型)中,只有性别以及碱性磷酸酶、白蛋白和甲胎蛋白的入组浓度与HCC的出现独立且显著相关。

结论

根据肝硬化患者发生HCC的风险,每隔3至6个月进行一次定期超声随访,能够在很大比例的患者中早期发现肝癌,可能改善疾病的预后。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验